I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Holweg, Cecile T.J.
128
results:
Search for persons
X
Format
Online (128)
Mediatypes
Articles (Online) (78)
OpenAccess-fulltext (50)
Sorted by: Relevance
Sorted by: Year
?
1
Effectiveness of omalizumab across different dosing regimen..:
Chase, Nicole M.
;
Littlejohn, Monica
;
Holweg, Cecile T.J.
...
Respiratory Medicine. 223 (2024) - p. 107537 , 2024
Link:
https://doi.org/10.1016/..
?
2
Sputum periostin is a biomarker of type 2 inflammation but ..:
Al‐Shaikhly, Taha
;
Murphy, Ryan C.
;
Lai, Ying
...
Respirology. 28 (2023) 5 - p. 491-494 , 2023
Link:
https://doi.org/10.1111/..
?
3
A genome-wide association study of chronic spontaneous urti..:
Chang, Diana
;
Hammer, Christian
;
Holweg, Cecile T.J.
...
Journal of Allergy and Clinical Immunology. 151 (2023) 5 - p. 1351-1356 , 2023
Link:
https://doi.org/10.1016/..
?
4
Similar response to omalizumab in children with allergic as..:
Witonsky, Jonathan
;
Elhawary, Jennifer R.
;
Millette, Lauren A.
...
The Journal of Allergy and Clinical Immunology: In Practice. 11 (2023) 9 - p. 2911-2913 , 2023
Link:
https://doi.org/10.1016/..
?
5
A Randomized Trial of a Composite T2-Biomarker Strategy Adj..:
Eastwood, Matthew C.
;
Busby, John
;
Jackson, David J.
...
The Journal of Allergy and Clinical Immunology: In Practice. 11 (2023) 4 - p. 1233-1242.e5 , 2023
Link:
https://doi.org/10.1016/..
?
6
A whole genome sequencing study of moderate to severe asthm..:
Chang, Diana
;
Hunkapiller, Julie
;
Bhangale, Tushar
...
Scientific Reports. 12 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
7
Impact of body mass index on omalizumab response in adults ..:
Geng, Bob
;
Dixon, Anne E.
;
Ko, Jinnie
...
Annals of Allergy, Asthma & Immunology. 128 (2022) 5 - p. 553-560 , 2022
Link:
https://doi.org/10.1016/..
?
8
Patients with allergic asthma have lower risk of severe COV..:
Murphy, Thomas R.
;
Busse, William
;
Holweg, Cecile T. J.
...
BMC Pulmonary Medicine. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
9
Efficacy, safety, and tolerability of lebrikizumab in adole..:
Szefler, Stanley J.
;
Roberts, Graham
;
Rubin, Adalberto S.
...
Clinical and Translational Allergy. 12 (2022) 7 - p. , 2022
Link:
https://doi.org/10.1002/..
?
10
Omalizumab in Asthma with Fixed Airway Obstruction: Post Ho..:
Hanania, Nicola A.
;
Fortis, Spyridon
;
Haselkorn, Tmirah
...
The Journal of Allergy and Clinical Immunology: In Practice. 10 (2022) 1 - p. 222-228 , 2022
Link:
https://doi.org/10.1016/..
?
11
Factors affecting adherence with treatment advice in a clin..:
Busby, John
;
Matthews, John G.
;
Chaudhuri, Rekha
...
European Respiratory Journal. 59 (2021) 4 - p. 2100768 , 2021
Link:
https://doi.org/10.1183/..
?
12
Defining the Efficacy of Omalizumab in Nasal Polyposis: A P..:
Damask, Cecelia
;
Chen, Meng
;
Holweg, Cecile T. J.
...
American Journal of Rhinology & Allergy. 36 (2021) 1 - p. 135-141 , 2021
Link:
https://doi.org/10.1177/..
?
13
Response to Omalizumab in Black and White Patients with All..:
Szefler, Stanley J.
;
Jerschow, Elina
;
Yoo, Bongin
...
The Journal of Allergy and Clinical Immunology: In Practice. 9 (2021) 11 - p. 4021-4028 , 2021
Link:
https://doi.org/10.1016/..
?
14
Composite type-2 biomarker strategy versus a symptom–risk-b..:
Heaney, Liam G
;
Busby, John
;
Hanratty, Catherine E
...
The Lancet Respiratory Medicine. 9 (2021) 1 - p. 57-68 , 2021
Link:
https://doi.org/10.1016/..
?
15
No difference in omalizumab efficacy in patients with asthm..:
Chen, Meng
;
Choo, Eugene
;
Yoo, Bongin
...
Annals of Allergy, Asthma & Immunology. 126 (2021) 6 - p. 666-673 , 2021
Link:
https://doi.org/10.1016/..
1-15